In a HDM mouse model, the expression of IL-23R by T cells, macrophages, and DCs was evaluated to underline the impact of IL-23-IL-23R signaling as a potential target in neutrophilic allergic airway inflammation for a novel asthma therapy. This evidence concerns the gene IL37 and asthma.